Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01
Published June 24, 2020 · Recall initiated: June 11, 2020
Summary
FDA records drug Class II recall D-1308-2020, published June 24, 2020 and initiated June 11, 2020. Recalling firm: Hikma Pharmaceuticals USA Inc.; Status: Terminated; Reported quantity: 82,426 vials; Lot: Lot #: AC0231, AC0235, exp. date 08/2021; AC0237, exp. date 09/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.
What to do
Voluntary: Firm initiated · Letter
Get an email if IRINOTECAN HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IRINOTECAN HYDROCHLORIDE
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0301439701019
- Lot
- Lot #: AC0231, AC0235, exp. date 08/2021; AC0237, exp. date 09/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAIrinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH,June 24, 2020
- FDAmetFORMIN HCL ER USP 500 mg, a) 30 tablets (NDC: 43063-428-30); b) 60 tablets (NDC: 43063-428-60); c) 90June 24, 2020
- FDAMetformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 50 count (NDC 50268-531-15); b) 90 count (NDCJune 24, 2020
- FDAIrinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial, Rx Only,July 11, 2018
- FDAIrinotecan Hydrochloride Injection, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial per carton, Rx only,November 13, 2013
- FDAIrinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only,November 13, 2013
Questions about this recall
Was Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01 recalled?
Yes. FDA published recall D-1308-2020 on June 24, 2020. Reported hazard: Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IRINOTECAN HYDROCHLORIDE. UPC: 0301439701019.